Doc I appreciate your enthusiasm in Path but you clearly are providing false claims.The rueters report states that the owners have difference in opinion about the buyout price and that one of the owners expects a minimum of $1.4 billion as a bid pice.This is all Reuters has come up with.Its funny how this gets twisted according to ones own interest.No where there is a mention that the owners want $1.4 instead of $1.2 accounting for Z patch sales... That's ridiculously funny imagination.Clearly the owners of LTS are looking for bucks for their investment....they are nt calculating Z sales revenues sitting at the negotiation table. That's the job of our CEO Mr.Anido to break his head with sales nos.Actually no where does anyone talk about nupath or Z patch when mentioning LTS relat stuff in articles...so that's that...let our CEO do the job instead of hoping others to work hard for path.
I can wrap up the things for you that happened since approval coz therez nothing much that happened after that.Ok so we got approved in Jan.All of us got excited at the potential and possibility of patch becoming a hit in the migraine circle.Mr.CEO was all positive about finding a partner and launching in Q4. The stock price was around $3.7 then. Then the blank days started...at every CC the CEO would say that he was excited about finding a partner and Q4 launch was all set to go. The stock price dropped to $3. Next quarter came and CEO repeated the same stuff maintaining his positivity about launch and partner.Stock dropped to $2.In between we got a news that company is moving to a bigger office, once again we all got excited thinking its D day....next cc came and CEO still said he is finding a partner but this time added launch is postponed...stock dropped to $1.something.....At this point we all are as clueless as you as to what's happening and what's the future ! Hope you are on page with us now.
Absolutely true you are ! Nupath is a very very small subset of patch manufacturers and LTS bidding war means nothing to Nupaths future. Nupaths $50 million market cap is peanuts compared to LTS bids in the order of billions. Claiming that LTS success and Nupaths success is interlinked is total exaggeration,moreover the LTS bidding war is mainly for patches for restless leg syndrome and parkinsons...no mention of migraine there.
Are you ready to bet your hard earned money to vouch for this man ? I mean will you ? We all just know the product is great...we cannot be sure that it isn't played with for big $$$$$ 's. This man ran the show so far in the pretext of a Q4 launch...the only consistent thing he said during all of 2013's CC was the Q4 launch and come Q4 end he casually says its postponed.So what's this mans annual report card hold ? Just a big fat fabricated LIE !
This man who has the reputation of being at some of the top places at top posts has been maintaining all through 2013 that a Q4 launch is on target,he then casually says on an 11th hour conference "updating" the world that the launch has been delayed#$%$? I seriously want to know what does he think of himself ? he is running a publicly traded company with numerous shareholders and stakeholders, and he just tells one fine morning that he doesn't want to launch the product and none of us should question him and simply sit back and wait it out for him to get up one morning and feel its ok to launch now ! What's this guys credibility ? Will anyone believe anything that this guys says in the future after this ? Is running a company with so much stake this easy to get away with ? That's wow ! He is behaving like a penny stock CEO that'll get bankrupt anytime.Total disregard for any protocol, acting like a CEO of a company operating in his backyard. What if he comes tomorrow and says, you know what we have just decided to drop partnering and shut this company off?
This is cake walk for shorties here....Now that its clear we are not going to have any news till next year and no launch in 2013, this stock would be milked by shorties in short term. What a predictable stock to short this ! Guess all we longs should be considering playing the short game for next 2 months while holding the core position for long term ! Common we all need to make some money in 2013 and this one is a no brainer short stock at this point !
Cn you be more precise as to who has put PATH on restrictive list ? From what i know Unless you are an insider you would not be able to get such informant (restrictive list) about any company
With LTS lohman being put up for sale, and 1st round of bids happening from mid October...wondering if that offer would have impact on paths partner finding hunt,is that what Anido is waiting to see, ie who is going to buy LTS ? Novartis just made a buyout of fourges for $1.5 billion in July 2012, are they going to buyout path,I guess not.But the buyer of LTS would sure have some impact on path I guess.But that's going to take some while , so I hedge towards a GIA at the moment, unless we are pleasantly surprised.Any thoughts?
Makes no difference as such until we hear some news about partnership or launch. Anyway path has not "earned" anything this quarter except for shareholders hatred .
A $40k loss in a million dollar portfolio doesn't even matter. Infact it will serve him well for filing the IR ! But I am $6k down in my $8k investment in path and thats hard to understand given I entered path right before approval...which I thought was the wisest investment made by me so far. I can give 100 reasons why I like PATH but at the end of the day I'll just be asked 1 question, 'Then why is your stock down 56%? and I am sure no financial expert has an answer to this !
Dont know how greedy the management was going into the negotiation discussion.
My bet is more than the value of the share, the weightage was given to ownership of stock after partnership.
Obviously our management wanted to keep the key piece of the deal with them which is why the discussions never materialized and the stock is where it is now.On the positive side the management is very hopeful of a clear winner here but it's not helping the stock at the moment due to impending launch and uncertainty.A quick emergency strategy meeting is needed to stop further damage.
Yes when the CEO entered path they were in an exciting position @$4 and after 9 months of his stint they are at $1.75 ! If we were to do the annual appraisal for MR. Anido, he would get a straight 0 out of 5 , Poor !
He has more stake at getting this back to $4 if not anything more to make his performance card look graceful next quarter !
At the end of the day (as Anido says often) its all about share price !
$1.92 is the grade given for PATH for its Z approval ! That's all matters and that's all everyone cares about !
$3.72... Dint average down after that coz whenever I decided to average down the stock price kept going lower and lower that I am still waiting.
I think it's a very honest and straight forward answer.We people are getting impatient to hear any news and getting excited about every thing that's happening with path.Whatever happens, Mr. CEO needs to thank the shareholders in this MB when everything works out well in the end.Something like loyal shareholder award ! On a lighter note , any nominations on who will win the loyal shareholder award here ? I think it's going to be a tough fight between DRJ and treene based on their message history.